Testonon E 250 mg Utinon

Description

Testonon E 250 mg Utinon — multi-ester testosterone blend from Utinon at 250 mg. Staggered ester release combines rapid onset with sustained activity. High-concentration formulations reduce injection volume.

Key Benefits

• Multi-ester blend — acute kick + long-tail coverage from one injection
• Classic Sustanon / Omnadren formulation (prop + phenyl + iso + deca)
• Twice-weekly pinning schedule covers all four ester kinetics
• Behaves functionally like testosterone enanthate for cycle planning
• Popular pharma-grade option where single-ester vials aren’t available
• Each unit dosed at 250 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 250–750 mg/week; TRT 100–200 mg/week. Split across at least 2 injections (Mon/Thu). Shorter esters in the blend push injection frequency — once-weekly produces noticeable troughs.

How It Works

Mixture of 4 testosterone esters: propionate (fast), phenylpropionate (short-medium), isocaproate (medium), decanoate (long). At the AR the active hormone is identical across esters; the blend provides staggered release kinetics for smoother coverage.

Pharmacokinetics

Composite release: propionate peaks in ~24 h, phenylpropionate ~2 days, isocaproate ~3–4 days, decanoate ~7–10 days. Net effect similar to enanthate but with a gentler peak. Steady-state in 4 weeks. PCT starts 2 weeks after last injection.

Potential Side Effects

Standard testosterone side-effect profile. Propionate fraction can cause PIP; some users prefer pure enanthate for tolerability. AI dose by bloodwork — hematocrit and E2 at week 6.

Cycle & Stacking Guide

Cycle base identical to enanthate: 12–16 weeks for mass/recomp, paired with secondary compounds per goal. Twice-weekly pinning mandatory. PCT (Clomid + Nolva) 14 days after last pin.

Manufacturer Notes

Utinon is an Iranian GMP producer with decades of domestic pharmaceutical experience. The catalogue features both injectable and oral formats.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.